Nanoscale Stiffness Distribution in Bone Metastasis

HTML  XML Download Download as PDF (Size: 1137KB)  PP. 219-228  
DOI: 10.4236/wjnse.2015.54023    4,557 Downloads   5,667 Views  Citations

ABSTRACT

Nanomechanical heterogeneity is expected to have an effect on elasticity, injury and bone remodelling. In normal bone, we have two types of cells (osteoclasts and osteoblasts) working together to maintain existing bone. Bone cancers can produce factors that make the osteoclasts work harder. This means that more bone is destroyed than rebuilt, and leads to weakening of the affected bone. We report here the first demonstration of the nanoscale stiffness distribution in bone metastases before and after treatment of animals with the bisphosphonate Risedronate, a drug which is currently used for the treatment of bone metastases in patients with advanced cancers. The strategy used here is applicable to a wide class of biological tissues and may serve as a new reflection for biologically inspired scaffolds technologies.

Share and Cite:

Richert, L. , Keller, L. , Wagner, Q. , Bornert, F. , Gros, C. , Bahi, S. , Clauss, F. , Bacon, W. , Clézardin, P. , Benkirane-Jessel, N. and Fioretti, F. (2015) Nanoscale Stiffness Distribution in Bone Metastasis. World Journal of Nano Science and Engineering, 5, 219-228. doi: 10.4236/wjnse.2015.54023.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.